EBS Cost of Revenue

Emergent Biosolutions Inc · Cost of Revenue

EBS logo

EBS Cost of Revenue

Latest reported$389.70M
EBS Cost of Revenue ($424.10M → $389.70M)
High-resolution chart · PNG

EBS cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Emergent Biosolutions Inc Cost of Revenue — Annual fiscal periods (USD)
Period endingCost of Revenue (USD)
392,300,000
668,200,000
689,300,000
644,500,000
980,400,000
714,200,000
622,900,000
462,000,000
277,300,000
244,000,000
216,845,000
206,684,000
182,060,000
169,308,000
42,171,000
47,114,000
46,262,000
34,081,000
40,309,000
24,125,000
31,603,000
30,102,000
0
24,569,000
424,100,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.